Bloomberg BNA has published Post-Grant Patent Practice, written by four former Administrative Patent Judges of the United States Patent and Trademark Office (USPTO). This authoritative new treatise analyzes many important legal procedures, including reissue, ex parte and inter partes reexamination, disclaimers, certificates of correction, and interference practice that are required of companies and their legal representatives after the successful acquisition of a patent on one of their products.
The treatise provides guidance to patent professionals regarding all USPTO post-issuance procedures that are designed to address possible mistakes made during the prosecution of a patent application, including mistakes made by the USPTO.
The America Invents Act (AIA), which took effect September 16, 2012, greatly expanded post-grant practice, particularly inter partes proceedings. Post-Grant Patent Practice analyzes the procedures introduced by the AIA, both in text and in charts, explaining them in detail, from pre-filing considerations through appeal to the U.S. Court of Appeals for the Federal Circuit, or, alternatively, to a district court and then to the Federal Circuit. Analyzed procedures include:
The authors of Post-Grant Patent Practice are distinguished former Administrative Patent Judges. Nancy J. Linck is a member of the intellectual property law firm of Rothwell, Figg, Ernst & Manbeck in Washington, DC, where she focuses on post-grant practice before the Office and works with the firm’s USPTO Trial Practice Group. Bruce H. Stoner, Jr., serves as Chairman of Greenblum & Bernstein P.L.C.’s Reexamination and Post-Grant Review Groupand as an expert witness and consultant on patent office practice and procedure. Lee E. Barrett is presently of counsel and a member of the Post-Grant Practice Group at Oblon, Spivak, McClelland, Maier & Neustandt, L.L.P. Carol A. Spiegel is a Master at Giles Rich American Inn of Court who maintains membership in the American Bar Association, the American Intellectual Property Law Association, and the American Society for Clinical Pathology. This treatise is available for sale directly from Bloomberg BNA and also will be available on the Bloomberg Law legal research system.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)